Prime Medicine, Inc.
PRME
$3.49
$0.195.89%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -197.34M | -199.28M | -202.01M | -195.88M | -219.25M |
| Total Depreciation and Amortization | 7.16M | 6.84M | 6.51M | 6.13M | 5.66M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.75M | 33.67M | 37.95M | 35.81M | 33.95M |
| Change in Net Operating Assets | 42.36M | 58.83M | 53.53M | 31.08M | -3.33M |
| Cash from Operations | -109.06M | -99.94M | -104.02M | -122.87M | -182.97M |
| Capital Expenditure | -6.03M | -7.06M | -7.39M | -7.29M | -7.34M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -82.81M | 60.69M | 65.14M | 75.75M | 68.83M |
| Cash from Investing | -88.84M | 53.62M | 57.75M | 68.46M | 61.49M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 138.95M | 38.71M | 38.55M | 171.08M | 171.27M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 12.00M | 6.00M | 6.00M | 24.80M | 24.80M |
| Cash from Financing | 150.95M | 44.71M | 44.55M | 195.88M | 196.07M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.95M | -1.60M | -1.72M | 141.47M | 74.58M |